Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Morning Journal cited a study published in the July 2020 issue of The American Journal of Managed Care® (AJMC®), titled “The Escalation of the Opioid Epidemic Due to COVID-19 and Resulting Lessons About Treatment Alternatives.” The study indicated that investing in modalities that promote building emotional resiliency and help address the factors that made patients susceptible to opioid reliance in the first place are key to addressing the growing opioid epidemic amid the pandemic.
A piece by WGNO spotlighted a study published in the June 2020 issue of AJMC®. The study, “Value-Based Insurance Design in Louisiana: Blue Cross Blue Shield’s Zero Dollar Co-pay Program,” found that enrollment in a value-based insurance design program that eliminated pharmacy co-pays for 4 chronic disease drug classes was associated with a large decline in health care spending.
An article by FOX 5 Washington DC referenced a study published in The American Journal of Accountable Care®, the sister journal of AJMC®. The study, “Current Value-Based Care Models Need Greater Emphasis on Specialty Care,” provided an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More